|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
|
|---|---|---|---|---|---|
| Collaboration revenue - related party | |||||
| License-related revenue | |||||
| Total revenue | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Income (loss) from operations | |||||
| Interest and other income (expense), net | |||||
| Interest expense | |||||
| Other income, net | |||||
| Total interest and other income (expense), net | |||||
| Net income (loss) | |||||
| Accretion of redeemable convertible preferred stock to redemption value | |||||
| Net income (loss) attributable to common stockholders | |||||
| Other comprehensive loss: | |||||
| Unrealized loss on marketable securities, net of tax | |||||
| Comprehensive income (loss) | |||||
| Net income (loss) per share - basic (in dollars per share) | |||||
| Weighted average commons shares outstanding—basic (shares) | |||||
| Net income (loss) per share - diluted (in dollars per share) | |||||
| Weighted average common shares outstanding—diluted (shares) |
Loading...
